Etravirine

Sort by

Etravirine Butanamide impurity

  • CAT NUMBER DCTI-C-3309
  • CAS NUMBER 2240161-92-4
  • MOLECULAR FORMULA C25H24BrN7O2
  • MOLECULAR WEIGHT 534.42

General Information

Etravirine Impurities and Etravirine

Daicel Pharma offers the best Etravirine impurities, such as Etravirine Butanamide impurity. It is vital for evaluating the quality, stability, and biological safety of Etravirine. In addition, Daicel Pharma specializes in the custom synthesis of Etravirine impurities and ensures their worldwide delivery.

Etravirine [CAS: 269055-15-4], a diarylpyrimidine (DAPY), along with other antiretroviral agents, treats patients with human immunodeficiency virus type 1 (HIV-1) infection. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is a second-generation NNRTI that has antiviral activity against HIV-1 strains. Further, it was approved by the US FDA.

Etravirine: Use and Commercial Availability

Etravirine is an orally administered drug for treating HIV infection in adults with prior exposure to HIV medicines. In combination with other NNRTIs and antiretroviral agents, Etravirine treats HIV infection and the acquired immunodeficiency syndrome (AIDS). It is effective against NNRTI resistance-associated mutations. It is available under the name Intelence.

Etravirine Structure and Mechanism of Action

Etravirine Structure and Mechanism of Action

The chemical name of Etravirine is 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile. The chemical formula for Etravirine is C20H15BrN6O, and its molecular weight is approximately 435.28g/mol.

Etravirine binds to reverse transcriptase (RT) directly. It disrupts the enzyme’s catalytic site and inhibits RNA-dependent and DNA-dependent DNA polymerase activities.

Etravirine Impurities and Synthesis

Impurities may form during the synthesis of Etravirine 1 that affect the safety, efficacy, and shelf-life. These impurities form during the synthesis, storage, or degradation of Etravirine. It is necessary to control and monitor the impurities of Etravirine to improve the safety, efficacy, and storage of the drug.

Daicel Pharma offers a comprehensive Certificate of Analysis (CoA) for Etravirine impurities, which includes Etravirine Butanamide impurity. A CoA is from a cGMP-compliant analytical facility. It contains the complete characterization data such as 1H NMR, 13C NMR, IR, MASS2, and HPLC purity. We give additional data like 13C-DEPT and CHN on request. Daicel Pharma can prepare any unidentified Etravirine impurity or degradation products under customs synthesis. In addition, Daicel Pharma offers highly purified isotope-labeled standards of Etravirine for bioanalytical research and BA/BE studies. We also provide a complete characterization report on delivery.

References
FAQ's

Frequently Asked Questions

Impurities during the synthesis and storage of drug substances are organic impurities. They include starting materials, intermediates, by-products, etc. Inorganic impurities form during manufacturing. They include heavy metals, inorganic salts, reagents, catalysts, etc.

Impurities detected in drug products can lead to drug recalls and regulatory actions against the drug manufacturers.

Etravirine undergoes degradation under base, acid, oxidation, thermal, humidity, and photolysis stress conditions.

LC-MS and UP-LC methods help in determining the Etravirine impurities.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart